Samada Research is focused on the development of safer advanced medicines and dietary aides.
Samada Research has:
- Proprietary processes that are currently used commercially to identify and remove potential carcinogens in pharmaceutical compositions.
- A promising abuse-resistant non-addictive opiate based analgesic agent (CC-408) in preclinical development
- Novel anti-inflammatory agents for delaying the onset and progression of autoimmune disease
Learn more about: